• JSH-23: Precision NF-κB Inhibitor for Inflammation Research

  2025-10-23

  JSH-23 stands out as a selective small molecule NF-κB inhibitor, uniquely targeting p65 nuclear translocation to modulate inflammation with minimal off-target effects. Its robust performance in both cell-based and in vivo models enables researchers to dissect NF-κB signaling with unprecedented clarity, paving the way for advanced applications in disease modeling and cytokine inhibition.

• JSH-23: A Transformative Tool for Dissecting NF-κB-Driven...

  2025-10-22

  Discover how JSH-23, a small molecule NF-κB inhibitor, revolutionizes inflammation research by enabling precise analysis of NF-κB p65 nuclear translocation and pro-inflammatory cytokine inhibition. This article uniquely explores JSH-23's mechanistic depth, translational applications, and its pivotal role in emerging in vivo models.

• JSH-23: Advanced Strategies in NF-κB Inhibition for Infla...

  2025-10-21

  Explore how JSH-23, a potent NF-κB inhibitor, redefines inflammation research with unique selectivity and translational relevance. Dive into comparative analyses, mechanistic insights, and emerging applications that set this small molecule apart in NF-κB signaling pathway studies.

93 records 7/7 page Previous First page 上5页 67